Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

During the Trading Day
82.00 -4.61 / -5.32%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
82.00 0.00 / 0.00%
 
Volume: 323.6K

Today’s Trading

Previous close86.61
Today’s open85.23
Day’s range79.81 - 85.85
Volume4,179,341
Average volume (3 months)2,192,493
Market cap$21.3B
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+157.80%
Earnings growth (next 5 years)+53.55%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book19.52

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-6.06-4.21%
ZTSZoetis Inc-0.72-1.76%
MYLMylan NV-0.94-1.83%
INCYIncyte Corp-0.09-0.13%
Data as of 4:01pm ET, 02/08/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$1.0B
Annual profit (last year)-$558.1M
Net profit margin-54.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers